| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/15/2013 | EP2590994A1 Vaccine against streptococcal infections based on recombinant proteins |
| 05/15/2013 | EP2590671A2 Dual variable domain immunoglobulins and uses thereof |
| 05/15/2013 | CN103108887A Novel antigen binding proteins |
| 05/15/2013 | CN103108886A Anti-IL-23 heterodimer specific antibodies |
| 05/15/2013 | CN103108885A Antibodies having reduced immunogenicity in a human |
| 05/15/2013 | CN103108657A A method of increasing the effect of an activated-potentiated form of an antibody |
| 05/15/2013 | CN103108656A Stabilized formulations containing anti-NGF antibodies |
| 05/15/2013 | CN103103197A CD138-resistant monoclonal antibody variable region sequence as well as preparation method and application thereof |
| 05/15/2013 | CN103102415A Bispecific monoclonai antibody capable of simultaneously detecting imidacloprid and parathion-methyl |
| 05/15/2013 | CN103102414A HER2-resistant protein monoclonal antibody and application thereof |
| 05/15/2013 | CN103102413A Soybean trypsin inhibitor antibody as well as preparation method and application thereof |
| 05/15/2013 | CN103102412A Humanized anti-nasopharyngeal-cancer LMP2A extracellular region antibody Fab and application thereof |
| 05/15/2013 | CN103102411A Method for preparing monoclonal antibody hybridomas aiming at glycosylation modified proteins |
| 05/15/2013 | CN103102410A Method for separating anti-rotavirus immunoglobulin from chicken egg |
| 05/15/2013 | CN103102394A B cell epitope peptide PUHI49 for hepatitis c virus (HCV) and application of B cell epitope peptide PUHI49 |
| 05/15/2013 | CN103102392A N-terminal polypeptide of retinoic acid induced protein 16 and preparation method and application of antibody thereof |
| 05/15/2013 | CN103102319A Melamine semiantigen, preparation method and application thereof |
| 05/15/2013 | CN103102300A Tetracycline hapten and its preparation method and use |
| 05/15/2013 | CN101946003B Anti-adam-15 antibodies and utilization of the same |
| 05/15/2013 | CN101421305B Antibodies against insulin-like growth factor I receptor and uses thereof |
| 05/15/2013 | CN101255195B Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 05/15/2013 | CN101066999B Recombinant anti-OPN monoclonal antibody and its preparation and use |
| 05/14/2013 | US8440807 A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same |
| 05/14/2013 | US8440806 Humanized anti-CD4 antibody with immunosuppressive properties |
| 05/14/2013 | US8440799 Methods of purifying anti A β antibodies |
| 05/14/2013 | US8440798 Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies |
| 05/14/2013 | US8440797 Human monoclonal antibody |
| 05/14/2013 | US8440796 Lenalidomide and thalidomide immunoassays |
| 05/14/2013 | US8440718 Modulation of inflammation related to columnar epithelia |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
| 05/14/2013 | US8440198 Compositions and methods for wound healing |
| 05/14/2013 | US8440197 KID3 and KID3 antibodies that bind thereto |
| 05/14/2013 | US8440196 Treatment for pancreatitis using IL-6 receptor antagonist antibodies |
| 05/14/2013 | US8440192 Bispecific binding agents for modulating biological activity |
| 05/14/2013 | US8440190 Antibody variants |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | US8440188 Therapeutic and diagnostic anti-HSP70 antibodies |
| 05/14/2013 | US8440186 P2X7 epitopes |
| 05/14/2013 | US8440167 Multimodal imaging of atherosclerotic plaque targeted to LOX-1 |
| 05/14/2013 | CA2758390A1 Stem cell targeting with dock-and-lock (dnl) complexes |
| 05/14/2013 | CA2720104C Method of discriminating bovine, thus discriminated bovine and kit for discriminating bovine |
| 05/14/2013 | CA2687377C Immunoglobulin fusion proteins |
| 05/14/2013 | CA2547446C Solid forms of anti-egfr-antibodies |
| 05/14/2013 | CA2480561C Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 05/14/2013 | CA2478297C Optimizing glycan processing in plants |
| 05/14/2013 | CA2468744C Hybrid antibodies |
| 05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 05/14/2013 | CA2453937C Antigenic polypeptides |
| 05/14/2013 | CA2427223C Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 05/14/2013 | CA2419270C Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 05/14/2013 | CA2393084C Immunoassay for neonicotinyl insecticides |
| 05/14/2013 | CA2388298C The use of csf-1 inhibitors |
| 05/14/2013 | CA2365639C Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 05/14/2013 | CA2263890C Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 05/14/2013 | CA2260079C Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 05/10/2013 | WO2013067517A2 Antibody and methods for selective inhibition of t-cell responses |
| 05/10/2013 | WO2013067509A1 Simultaneous purification of cell components |
| 05/10/2013 | WO2013067492A1 Isolated b7-h4 specific compositions and methods of use thereof |
| 05/10/2013 | WO2013067355A1 Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs |
| 05/10/2013 | WO2013067098A1 Anti-kdr antibodies and methods of use |
| 05/10/2013 | WO2013067060A1 Anti-gpr49 antibodies |
| 05/10/2013 | WO2013067057A1 Anti-gpr49 antibodies |
| 05/10/2013 | WO2013067055A1 Methods of blocking cancer stem cell growth |
| 05/10/2013 | WO2013067054A1 Antibodies and methods of treating cancer |
| 05/10/2013 | WO2013066866A1 Antibody formulations |
| 05/10/2013 | WO2013066761A1 Method for preparing antibodies having improved properties |
| 05/10/2013 | WO2013066726A1 T-cell receptor clonotypes shared among ankylosing spondylitis patients |
| 05/10/2013 | WO2013066707A1 Chromatography process for resolving heterogeneous antibody aggregates |
| 05/10/2013 | WO2013065708A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain |
| 05/10/2013 | WO2013065343A1 Peptide-hinge-free flexible antibody-like molecule |
| 05/10/2013 | WO2013064810A1 Pulmonary hypertension |
| 05/10/2013 | WO2013064701A2 Bispecific antibodies and methods for isolating same |
| 05/10/2013 | WO2013064700A2 Chimeric polypeptides and methods of use |
| 05/10/2013 | WO2013064685A1 Antigen binding protein and its use as addressing product for the treatment cancer |
| 05/10/2013 | WO2013064684A1 Antigen binding protein and its use as addressing product for the treatment of cancer |
| 05/10/2013 | WO2013064443A1 In vivo adcc model |
| 05/10/2013 | WO2013063874A1 Monoclonal antibody against human non-small-cell lung carcinoma and use thereof |
| 05/10/2013 | WO2013063702A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 05/10/2013 | WO2013040472A3 Compositions and methods related to dna damage repair |
| 05/10/2013 | WO2013038016A3 Monoclonal antibodies for detection of high-risk human papillomavirus oncoprotein e7 |
| 05/10/2013 | WO2013014208A3 Anti-vegf single variable domains fused to fc domains |
| 05/10/2013 | WO2013006449A3 Anti-properdin antibodies and uses thereof |
| 05/10/2013 | WO2012171030A3 Method and apparatus for antibody production and purification |
| 05/10/2013 | WO2012160448A3 Anti-kir antibodies for the treatment of inflammatory disorders |
| 05/10/2013 | WO2012149197A3 Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| 05/10/2013 | CA2854457A1 Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs |
| 05/10/2013 | CA2854233A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 05/10/2013 | CA2854153A1 Anti-kdr antibodies and methods of use |
| 05/10/2013 | CA2854152A1 Pulmonary hypertension |
| 05/10/2013 | CA2854126A1 Antigen binding protein and its use as addressing product for the treatment of cancer |
| 05/10/2013 | CA2853951A1 Antibodies and methods of treating cancer |
| 05/10/2013 | CA2853943A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | CA2853858A1 Methods for reducing the frequency and severity of acute exacerbations of asthma |
| 05/10/2013 | CA2853816A1 Methods of preparing lyophilized spherical-shaped pellets of biological materials |
| 05/10/2013 | CA2853809A1 Method for preparing antibodies having improved properties |
| 05/10/2013 | CA2853687A1 Antibody and methods for selective inhibition of t-cell responses |
| 05/10/2013 | CA2853230A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain |
| 05/10/2013 | CA2851941A1 Antigen binding protein and its use as addressing product for the treatment of cancer |